| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.001 | 35.708 | 52.879 | 43.852 | 38.918 | 38.667 | 37.634 | 34.918 | 37.276 | 40.813 |
| Total Income - EUR | 42.254 | 45.921 | 62.588 | 55.481 | 48.380 | 44.924 | 37.681 | 38.973 | 52.785 | 41.089 |
| Total Expenses - EUR | 48.828 | 27.553 | 27.420 | 30.211 | 38.682 | 36.383 | 33.175 | 35.374 | 39.788 | 34.829 |
| Gross Profit/Loss - EUR | -6.573 | 18.368 | 35.168 | 25.270 | 9.698 | 8.540 | 4.506 | 3.599 | 12.997 | 6.260 |
| Net Profit/Loss - EUR | -7.832 | 17.910 | 34.542 | 24.716 | 9.214 | 8.292 | 4.223 | 3.256 | 12.527 | 5.212 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Nicodin Gyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 93.610 | 82.005 | 69.138 | 85.231 | 66.079 | 49.146 | 41.240 | 33.510 | 26.037 | 88.041 |
| Current Assets | 1.155 | 12.099 | 16.943 | 3.265 | 14.367 | 20.646 | 21.256 | 28.558 | 24.919 | 79.096 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 173 | 363 | 2.148 | 883 | 1.875 | 48 | 710 | 323 | 1.258 | 53.615 |
| Cash | 982 | 11.736 | 14.795 | 2.382 | 12.492 | 20.598 | 20.546 | 28.234 | 23.661 | 25.480 |
| Shareholders Funds | -105.209 | -86.224 | -50.223 | -24.586 | -14.896 | -6.322 | -1.959 | 1.291 | 13.814 | 18.949 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 154.227 | 180.328 | 111.149 | 97.891 | 89.762 | 76.115 | 64.455 | 61.490 | 37.312 | 95.469 |
| Income in Advance | 45.746 | 35.434 | 25.155 | 15.192 | 5.580 | 0 | 0 | 0 | 0 | 52.827 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicodin Gyn Srl